The approval of two new breast cancer drugs in Scotland represented a “significant leap forward” and would give patients “extra time with their loved ones”, a charity has said, as they become just some of the latest medicines to be approved for use in the NHS.
Enhertu and Tukysa were given the green light for use by scientists at the Scottish Medicines Consortium (SMC) on Monday, alongside non-small-cell, lung cancer drug Tagrisso and eczema medication, Adtralza.
